top of page

AccuLab Optical Blog

Search

The 1.74 Lens Shortage: Why ECPs Need the Freedom to Choose

  • Writer: AccuLab Optical
    AccuLab Optical
  • Jul 29
  • 4 min read

By Jon J. Trutt

Published: 7/29/2026


Recently, many eye care professionals received a letter explaining that supply constraints affecting 1.74 high-index lens material could impact availability in the coming months. The recommendation was to reserve 1.74 material for higher prescriptions while fitting many patients between +7.00 and -7.00 diopters with 1.67 high-index material or comparable alternatives.


The goal behind these recommendations may be to manage supply challenges and avoid delays, but it raises an important question:


When it comes to choosing the best lens for a patient, who should make that decision, the eye care professional or the supplier?


Imagine visiting your physician and being told that a medication or medical device they believe is the best fit for you is unavailable through their preferred supplier, so they are recommending something else instead.


Most patients would naturally ask:


"Is that option available somewhere else?"


If another trusted source can provide the same solution, most healthcare professionals would consider it because their responsibility is to the patient first.


Optical should be no different.


Patients Are Not One-Size-Fits-All


Every patient is different.


Two people with the exact same prescription may have completely different needs. One patient may want the thinnest possible lens for cosmetic reasons. Another may prioritize weight. Another may have chosen a frame where a specific material provides the best overall result.


Those decisions happen at the dispensing table, during conversations between the patient and their eye care professional.


That is where they should happen.


Optometrists and opticians have the experience and knowledge to evaluate the complete picture, not just the prescription. They understand their patient's lifestyle, expectations, frame choice, and visual needs. They should have the ability to recommend the lens solution they believe is best, rather than just selecting from what is easiest to get.


Supply challenges are a reality in every industry. But supply challenges should not automatically direct patient care.


A Supply Challenge at One Supplier Does Not Mean Fewer Options Everywhere


Here's the thing: a supply limitation at one supplier does not mean the entire optical industry faces the same limitation.


Many independent labs continue to provide 1.74 high-index lenses without restricting prescription ranges or asking practices to change their recommendations.


At AccuLab, it’s business as usual. We never lost access to 1.74 material, and we continue to support practices who choose it when they think it’s the best solution for their patients.


If one supplier cannot provide a material without restrictions, is that truly an industry-wide shortage? Or just a limitation within that supplier's own network?

If another lab can provide that same material, the patient is not out of options.


That distinction matters because ECPs shouldn’t have to reduce patient selection just because one supplier has limited availability.


The Value of Independent Labs


This is exactly why independent labs are important.


Every laboratory manages its supply chain differently. We work with different manufacturing partners, maintain different inventory strategies, and build relationships that allow us to serve practices in different ways.


That diversity creates strength.


When one supplier experiences challenges, indie labs can provide another option. That isn't just competition. It’s resilience, freedom, and the ability for ECPs to choose the solutions they believe are best for their patients.


A strong optical industry depends on flexibility. Multiple suppliers allow ECPs to continue making decisions based on what their patients need, rather than being forced into a limited set of options.


Supply Challenges Should Encourage Solutions, Not Limit Selection


At the end of the day, ECPs know their patients best. They should have the freedom to recommend the lens solution they believe makes the most sense, not the one that is most convenient to source.


If a material provides meaningful benefits for a patient and is available through another reputable lab, that option deserves consideration.


Supply challenges should encourage practices to explore additional resources, not just accept fewer choices.


The Bigger Conversation Is About Choice


This discussion is about more than one lens material.


It’s about maintaining the ability of ECPs to make decisions based on their expertise and their patients' needs.


When options become limited, ECPs lose the flexibility to recommend the solution they believe is best for each patient. Patients may lose access to solutions their ECP believes would provide the best balance of optics, appearance, comfort, and performance. Practices lose flexibility. And the industry loses the competition that drives innovation.


Progress has never been created by reducing choices. It has always come from expanding possibilities.


Keeping ECPs in Control of Patient Decisions


Independent labs exist because practices deserve options.


They provide alternatives when a single supplier can’t meet every need. They provide flexibility when the industry faces challenges. Most importantly, they help ensure that ECPs remain in control of the decisions that affect their patients.


At AccuLab, we believe our role is simple: support the decisions you make for your patients.


If you determine that 1.74 is the best material for your patient, our job is to help you provide it.


Because the best decisions in optical should always be made at the dispensing table; not in an inventory meeting.


Contact AccuLab today if you need 1.74 material!


· 800-688-3904

 
 
 

Comments


bottom of page